Your browser is no longer supported. Please, upgrade your browser.
BioDelivery Sciences International, Inc.
Index- P/E12.30 EPS (ttm)0.30 Insider Own1.70% Shs Outstand98.70M Perf Week20.59%
Market Cap345.05M Forward P/E9.87 EPS next Y0.37 Insider Trans44.87% Shs Float96.11M Perf Month14.24%
Income31.20M PEG0.49 EPS next Q0.03 Inst Own69.00% Short Float2.82% Perf Quarter-10.87%
Sales165.70M P/S2.08 EPS this Y233.10% Inst Trans0.35% Short Ratio1.68 Perf Half Y1.93%
Book/sh1.24 P/B2.98 EPS next Y61.21% ROA12.60% Target Price6.79 Perf Year-12.14%
Cash/sh1.08 P/C3.43 EPS next 5Y25.00% ROE27.50% 52W Range2.50 - 4.68 Perf YTD19.03%
Dividend- P/FCF- EPS past 5Y18.50% ROI17.50% 52W High-22.14% Beta0.82
Dividend %- Quick Ratio2.10 Sales past 5Y26.50% Gross Margin85.10% 52W Low45.60% ATR0.20
Employees176 Current Ratio2.40 Sales Q/Q4.30% Oper. Margin24.40% RSI (14)71.82 Volatility8.92% 5.25%
OptionableYes Debt/Eq0.48 EPS Q/Q-26.60% Profit Margin18.80% Rel Volume0.94 Prev Close3.69
ShortableYes LT Debt/Eq0.45 EarningsNov 03 BMO Payout0.00% Avg Volume1.61M Price3.64
Recom2.10 SMA2016.05% SMA5021.70% SMA2003.35% Volume1,194,662 Change-1.36%
Nov-04-21Downgrade H.C. Wainwright Buy → Neutral $6 → $4.50
Apr-22-20Initiated Northland Capital Outperform $9
Jan-09-20Initiated Piper Sandler Overweight $9
Mar-20-19Initiated SunTrust Buy $7
Jan-31-19Resumed Janney Buy $5
Jan-26-18Initiated Seaport Global Securities Buy $5
Aug-14-17Resumed Cantor Fitzgerald Overweight $4.50
Aug-10-17Reiterated H.C. Wainwright Buy $4 → $5
May-26-17Initiated H.C. Wainwright Buy $4
May-17-17Upgrade Cantor Fitzgerald Neutral → Overweight
May-12-16Reiterated Piper Jaffray Overweight $6 → $4
May-11-16Downgrade Cantor Fitzgerald Buy → Hold
May-04-16Reiterated FBR Capital Outperform $12 → $9
Mar-14-16Reiterated Laidlaw Buy $17 → $11
Mar-11-16Reiterated FBR Capital Outperform $13 → $12
Feb-08-16Initiated Piper Jaffray Overweight
Nov-10-15Reiterated FBR Capital Mkt Perform $17 → $14
Nov-04-15Initiated Cantor Fitzgerald Buy
May-12-15Reiterated Cantor Fitzgerald Buy $17 → $12
May-11-15Reiterated ROTH Capital Buy $16 → $14
Jan-24-22 04:55PM  
Jan-21-22 10:49AM  
Jan-20-22 08:00AM  
Jan-01-22 06:50AM  
Dec-28-21 07:29AM  
Dec-20-21 07:51PM  
Dec-03-21 11:31AM  
Dec-02-21 04:57AM  
Nov-22-21 10:41AM  
Nov-15-21 11:47AM  
Nov-10-21 07:54AM  
Nov-03-21 09:15AM  
Nov-02-21 07:49AM  
Oct-27-21 03:04PM  
Oct-21-21 08:00AM  
Oct-20-21 08:00AM  
Oct-03-21 09:09AM  
Sep-30-21 08:00AM  
Sep-27-21 02:01PM  
Sep-21-21 11:36AM  
Sep-14-21 12:51PM  
Sep-09-21 08:30AM  
Sep-07-21 09:28AM  
Sep-03-21 11:31AM  
Aug-16-21 08:00AM  
Aug-10-21 10:45AM  
Aug-04-21 07:00PM  
Jul-28-21 03:03PM  
Jul-22-21 08:00AM  
Jul-13-21 06:12AM  
Jun-20-21 03:46AM  
Jun-08-21 03:16PM  
May-06-21 10:00PM  
Apr-29-21 05:00PM  
Apr-20-21 08:00AM  
Apr-09-21 11:30AM  
Mar-30-21 07:22AM  
Mar-22-21 01:33AM  
Mar-10-21 03:30PM  
Mar-03-21 12:30PM  
Feb-17-21 08:00AM  
Feb-11-21 08:00AM  
Feb-08-21 10:11AM  
Feb-05-21 01:07AM  
Jan-15-21 09:00AM  
Dec-21-20 11:54PM  
Dec-19-20 06:11PM  
Dec-05-20 11:31AM  
Nov-20-20 08:30AM  
Nov-17-20 09:40AM  
Nov-11-20 08:30AM  
Nov-07-20 08:02AM  
Nov-06-20 06:00AM  
Nov-05-20 07:00PM  
Nov-04-20 05:31PM  
Oct-23-20 08:00AM  
Sep-28-20 10:41AM  
Sep-24-20 10:46AM  
Sep-14-20 12:06PM  
Sep-11-20 08:00AM  
Sep-04-20 11:31AM  
Sep-03-20 08:00AM  
Aug-10-20 09:08AM  
Aug-06-20 10:05AM  
Aug-05-20 09:05AM  
Jul-29-20 12:33PM  
Jul-27-20 04:01PM  
Jul-12-20 07:39PM  
Jun-10-20 05:44PM  
Jun-09-20 11:38PM  
Jun-06-20 11:31AM  
May-29-20 12:17PM  
May-26-20 10:43AM  
May-11-20 08:30AM  
May-09-20 05:01PM  
May-08-20 10:52AM  
May-07-20 06:35PM  
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sirgo Mark ADirectorDec 02Buy2.6918,58749,9991,159,182Dec 06 08:06 AM
Singh VanilaDirectorNov 22Option Exercise0.005,333028,167Nov 23 05:01 PM
KOTLER KEVINDirectorNov 19Buy3.06100,000306,0005,158,489Nov 22 07:37 AM
KOTLER KEVINDirectorNov 12Buy3.20100,000320,0005,058,489Nov 15 07:56 AM
Sirgo Mark ADirectorNov 11Buy3.2016,00051,2001,130,595Nov 12 08:03 AM
KOTLER KEVINDirectorNov 05Buy3.47257,800894,5664,958,489Nov 09 10:28 AM
Bailey Jeffrey AllenChief Executive OfficerNov 04Option Exercise0.0053,333099,800Nov 08 04:40 PM
Singh VanilaDirectorAug 23Option Exercise0.004,000022,834Aug 25 04:39 PM
Sirgo Mark ADirectorAug 23Option Exercise0.004,00001,114,595Aug 25 04:37 PM
KOTLER KEVINDirectorAug 10Option Exercise2.9315,00043,9504,700,689Aug 10 06:19 PM
Singh VanilaDirectorAug 06Option Exercise0.006,750018,834Aug 10 06:26 PM
Sirgo Mark ADirectorAug 06Option Exercise0.004,00001,110,595Aug 10 06:24 PM
Bailey Jeffrey AllenChief Executive OfficerAug 06Option Exercise0.005,567046,467Aug 10 06:23 PM
Watson W. MarkDirectorAug 06Option Exercise0.0030,000082,979Aug 10 06:21 PM
KOTLER KEVINDirectorAug 06Option Exercise0.0030,00004,685,689Aug 10 06:19 PM
Greenleaf PeterDirectorAug 06Option Exercise0.0035,000094,788Aug 10 06:17 PM
Davis Todd CDirectorAug 06Option Exercise0.0030,0000244,523Aug 10 06:15 PM
KOTLER KEVINDirectorMay 13Buy3.2550,000162,5004,655,689May 13 05:38 PM
Sirgo Mark ADirectorMay 13Buy3.163,0009,4801,106,595May 13 05:36 PM
KOTLER KEVINDirectorMay 12Buy3.24100,000324,0004,605,689May 13 05:38 PM
Sirgo Mark ADirectorMay 12Buy3.245,00016,2001,103,595May 13 05:36 PM
KOTLER KEVINDirectorMay 11Buy3.16150,000474,0004,505,689May 13 05:38 PM
Sirgo Mark ADirectorMay 11Buy3.167,50023,7001,098,595May 13 05:36 PM
Plesha Scott M.See RemarksMar 12Option Exercise0.0020,8340299,874Mar 16 04:57 PM
Bailey Jeffrey AllenChief Executive OfficerMar 09Option Exercise0.005,333040,900Mar 11 04:14 PM
Vollins JamesSee RemarksFeb 08Sale4.163,83315,9450Feb 08 05:46 PM
Vollins JamesSee RemarksFeb 04Sale3.978,30332,9633,833Feb 08 05:46 PM
Plesha Scott M.See RemarksFeb 01Option Exercise0.0013,3330258,206Feb 02 06:17 PM
Smith Thomas BChief Medical OfficerFeb 01Option Exercise0.007,667019,954Feb 02 05:55 PM
Vollins JamesSee RemarksFeb 01Option Exercise0.003,833012,136Feb 02 05:59 PM
Coelho Mary TheresaSee RemarksFeb 01Sale3.873,46013,39030,619Feb 02 07:12 PM
Coelho Mary TheresaSee RemarksJan 29Option Exercise0.0010,190034,079Feb 02 07:12 PM
Plesha Scott M.See RemarksJan 29Option Exercise0.0010,8700244,873Feb 02 06:17 PM
Smith Thomas BChief Medical OfficerJan 29Option Exercise0.007,548012,287Feb 02 05:55 PM
Vollins JamesSee RemarksJan 29Option Exercise0.008,30308,303Feb 02 05:59 PM